Journal of Clinical Endocrinology & Metabolism, Vol 60, 1019-1024, Copyright © 1985 by Endocrine Society

ARTICLES

Management of hyperthyroidism in children and adolescents

JI Hamburger

Between 1961 and 1984, 262 patients with hyperthyroidism due to Graves' disease between the ages of 3 and 18 yr were treated in the author's clinic. This paper compares the results of different treatment methods. Initial treatment was surgery for 7 patients, radioiodine for 73, and an antithyroid drug for 182. Seven drug-treated patients subsequently had surgery. Of 14 surgically treated patients, 5 relapsed and received radioiodine, 5 became hypothyroid, 3 were lost to follow-up, and 1 remained euthyroid. Sixteen drug-treated patients were lost to follow- up; 7 are still taking drugs. Of the remaining 99 drug-treated patients not achieving remission, 92 received radioiodine, and 7 had surgery (1 later relapsed and received radioiodine). The principal reasons for abandoning drugs were toxicity, noncompliance, poor control, and failure to achieve sustained remissions. Of 61 drug-treated patients who achieved remission, 22 relapsed (21 were treated with radioiodine and 1 with drug). Remissions after antithyroid drug therapy persist in 39 patients, 2 of whom are now hypothyroid and 10 of whom have been in remission less than 2 yr. Of the 239 subjects whose treatment is complete, 191 (80%) ultimately had radioiodine. One radioiodine treatment eliminated hyperthyroidism in 163 patients, 2 treatments were effective in 17, and 3 treatments were effective in 1. The remaining 5 patients were lost to follow-up after radioiodine before the outcome of therapy could be determined. No increase in congenital abnormalities was found in 63 children of these patients, regardless of treatment. Radioiodine is a safe, simple, and economical therapy for patients with hyperthyroidism and is now considered the initial treatment of choice for such patients.

This article has been cited by other articles:

				N. S. Glaser, D. M. Styne, and for the Organization of Pediatric Endocrinologists Predicting the Likelihood of Remission in Children With Graves' Disease: A Prospective, Multicenter Study Pediatrics, March 1, 2008; 121(3): e481 - e488. [Abstract] [Full Text] [PDF]

				S. A. Rivkees and C. Dinauer An Optimal Treatment for Pediatric Graves' Disease Is Radioiodine J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 797 - 800. [Abstract] [Full Text] [PDF]

				J. A. Lee, M. M. Grumbach, and O. H. Clark The Optimal Treatment for Pediatric Graves' Disease Is Surgery J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 801 - 803. [Full Text] [PDF]

				P Dharmaraj and A Grueters The management of thyrotoxicosis in a pre-pubertal child with 18p deletion syndrome Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S145 - S147. [Abstract] [Full Text] [PDF]

				S. Rivkees Radioactive Iodine Use in Childhood Graves' Disease: Time to Wake Up and Smell the I-131 J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4227 - 4228. [Full Text] [PDF]

				C. H. Read Jr., M. J. Tansey, and Y. Menda A 36-Year Retrospective Analysis of the Efficacy and Safety of Radioactive Iodine in Treating Young Graves' Patients J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4229 - 4233. [Abstract] [Full Text] [PDF]

				G Birrell and T Cheetham Juvenile thyrotoxicosis; can we do better? Arch. Dis. Child., August 1, 2004; 89(8): 745 - 750. [Abstract] [Full Text] [PDF]

				S. A. Rivkees and E. A. Cornelius Influence of Iodine-131 Dose on the Outcome of Hyperthyroidism in Children Pediatrics, April 1, 2003; 111(4): 745 - 749. [Abstract] [Full Text] [PDF]

				P. M. Kadmon, R. B. Noto, C. M. Boney, G. Goodwin, and P. A. Gruppuso Thyroid Storm in a Child following Radioactive Iodine (RAI) Therapy: A Consequence of RAI Versus Withdrawal of Antithyroid Medication J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1865 - 1867. [Abstract] [Full Text]

				L. Lazar, O. Kalter-Leibovici, A. Pertzelan, N. Weintrob, Z. Josefsberg, and M. Phillip Thyrotoxicosis in Prepubertal Children Compared with Pubertal and Postpubertal Patients J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3678 - 3682. [Abstract] [Full Text]

				S. A. Rivkees, C. Sklar, and M. Freemark The Management of Graves' Disease in Children, with Special Emphasis on Radioiodine Treatment J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3767 - 3776. [Full Text]

				T D CHEETHAM, I A HUGHES, N D BARNES, and E P WRAIGHT Treatment of hyperthyroidism in young people Arch. Dis. Child., March 1, 1998; 78(3): 207 - 209. [Full Text]